179 related articles for article (PubMed ID: 38314323)
1. Severe Xerostomia Induced by Multiple Systemic Diseases in a Patient with Psoriasis Vulgaris: A Case Report and Literature Review.
Novianti Y; Hidayat W; Rosa DE
Int Med Case Rep J; 2024; 17():77-88. PubMed ID: 38314323
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture as a Complementary Method of Traditional Psoriasis Treatment: Myth or Reality?
Mahović D; Mrsić F
Acta Dermatovenerol Croat; 2016 Aug; 24(3):221-2. PubMed ID: 27663925
[TBL] [Abstract][Full Text] [Related]
4. [Implications of xerostomia in oral dis-homeostasis].
Ursache M; Grădinaru I; Nechifor M; Cherciu-Ciubotaru B
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):432-7. PubMed ID: 17802957
[TBL] [Abstract][Full Text] [Related]
5. Oral Lesions in Patients With Psoriasis: Prevalence and Association With Its Clinical and Epidemiological Characteristics.
Altemir A; Melé-Ninot G; Lázaro-Simó AI; Iglesias-Sancho M; Quintana-Codina M; Arandes J; Carrera-Morodo M; Salleras-Redonnet M
Actas Dermosifiliogr; 2022 May; 113(5):459-466. PubMed ID: 35697405
[TBL] [Abstract][Full Text] [Related]
6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
7. Acitretin : A Review of its Pharmacology and Therapeutic Use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
[TBL] [Abstract][Full Text] [Related]
8. Therapy of moderate and severe psoriasis.
Claes C; Kulp W; Greiner W; von der Schulenburg JM; Werfel T
GMS Health Technol Assess; 2006 Apr; 2():Doc07. PubMed ID: 21289958
[TBL] [Abstract][Full Text] [Related]
9. Salivary aquaporin-3 as a screening biomarker for xerostomia in patients with periodontal disease and the effects of xerostomia on oral health-related quality of life.
Atif S; Abdul Wahab N; Ghafoor S; Azlina A; Tauseef A; Rana S; Saeed MQ
PLoS One; 2023; 18(4):e0283995. PubMed ID: 37027451
[TBL] [Abstract][Full Text] [Related]
10. Study of the oral mucosa in 200 consecutive patients with psoriasis.
Hietanen J; Salo OP; Kanerva L; Juvakoski T
Scand J Dent Res; 1984 Feb; 92(1):50-4. PubMed ID: 6585911
[TBL] [Abstract][Full Text] [Related]
11. Xerostomia due to systemic disease: a review of 20 conditions and mechanisms.
Mortazavi H; Baharvand M; Movahhedian A; Mohammadi M; Khodadoustan A
Ann Med Health Sci Res; 2014 Jul; 4(4):503-10. PubMed ID: 25221694
[TBL] [Abstract][Full Text] [Related]
12. Clinical Treatment Study of Secondary Multiple Squamous Cell Carcinoma with Psoriasis Vulgaris.
Han SN; Feng SJ; Ai DF
J Oncol; 2022; 2022():9529681. PubMed ID: 35035485
[TBL] [Abstract][Full Text] [Related]
13. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
14. Oral changes in patients with psoriasis.
Sobecka-Frankiewicz M; Rudnicka J; Iwanicka-Grzegorek E; Mielczarek A
Int J Dermatol; 2023 May; 62(5):604-610. PubMed ID: 35834660
[TBL] [Abstract][Full Text] [Related]
15. Oral and ocular late effects in head and neck cancer patients treated with radiotherapy.
Westgaard KL; Hynne H; Amdal CD; Young A; Singh PB; Chen X; Rykke M; Hove LH; Aqrawi LA; Utheim TP; Herlofson BB; Jensen JL
Sci Rep; 2021 Feb; 11(1):4026. PubMed ID: 33597629
[TBL] [Abstract][Full Text] [Related]
16. Oral Manifestations of Systemic Lupus Erythematosus: A Systematic Review.
García-Ríos P; Pecci-Lloret MP; Oñate-Sánchez RE
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231212
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of 'psoriatic nephropathy'.
Zadrazil J; Tichý T; Horák P; Nikorjaková I; Zíma P; Krejcí K; Strébl P
J Nephrol; 2006; 19(3):382-6. PubMed ID: 16874702
[TBL] [Abstract][Full Text] [Related]
18. Temporomandibular Disorders and Oral Features in Systemic Lupus Erythematosus Patients: An Observational Study of Symptoms and Signs.
Crincoli V; Piancino MG; Iannone F; Errede M; Di Comite M
Int J Med Sci; 2020; 17(2):153-160. PubMed ID: 32038098
[No Abstract] [Full Text] [Related]
19. Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis.
Sugimoto E; Matsuda H; Shibata S; Mizuno Y; Koyama A; Li L; Taira H; Ito Y; Awaji K; Yamashita T; Sato S
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109382
[TBL] [Abstract][Full Text] [Related]
20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
